Steve Qing Yang, PhD - Publications
Affiliations: | 1986-1989 | Biology | Fudan university, Shanghai, Shanghai Shi, China |
1989-1991 | Michigan Technological University, USA | ||
1991-1997 | Medicinal Chemistry | University of California, San Francisco, San Francisco, CA | |
1997-1999 | Strategic Decision Group | ||
1999-2001 | IntroBiotics | ||
2001-2010 | Pfizer, Inc., San Diego, CA, United States | ||
2011-2014 | AstraZeneca LP, Canóvanas, Canóvanas, Puerto Rico | ||
2014- | WuXi AppTec |
Year | Citation | Score | |||
---|---|---|---|---|---|
1998 | Yang SQ, Craik CS. Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator Journal of Molecular Biology. 279: 1001-1011. PMID 9642077 DOI: 10.1006/Jmbi.1998.1749 | 0.42 | |||
1998 | Yang SQ, Wang CI, Gillmor SA, Fletterick RJ, Craik CS. Ecotin: a serine protease inhibitor with two distinct and interacting binding sites. Journal of Molecular Biology. 279: 945-57. PMID 9642073 DOI: 10.1006/Jmbi.1998.1748 | 0.417 | |||
Show low-probability matches. |